Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | TYMS | P04818 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 1/20 | 0.72 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.72 |
| ▸ | DHFR | P00374 | 9/20 | 0.66 |
| ▸ | TLR4 | O00206 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | GLA | P06280 | 1/20 | 0.60 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Folic Acid SCHEMBL28298890 | 1.00 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL12148554 | 0.99 | KDM4E (0.73) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL3878 | 0.99 | KDM4E (0.73) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL6470174 | 0.99 | KDM4E (0.73) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL29677832 | 0.99 | KDM4E (0.73) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL23388805 | 0.98 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL12497751 | 0.98 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL652283 | 0.98 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL22441084 | 0.98 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL19837676 | 0.98 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119497716-A | Crystal form of ENPP1 inhibitor | 石药集团中奇制药技术（石家庄）有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-112999122-B | Anti-wrinkle moisturizing eye cream and preparation method thereof | 江西建昌帮食疗科技有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-110317388-A | A kind of packaging material and its preparation method and application directly contacted with drug | 奥星衡迅生命科技（上海）有限公司 | 2019-10-11 | — | — | CN | claimed |
| CN-110122809-A | A kind of diabetes nutritive yam reinforcing powder | 熊吉素 | 2019-08-16 | — | — | CN | claimed |
| CN-109731075-A | Grow Chinese medicine composition, cell nutritious element and the application method of pancreas nourishing the liver control sugar therapy | 赵浩淋 | 2019-05-10 | — | — | CN | claimed |
| US-12414977-B2 | Method of administering seaberry and saw palmetto extracts to inhibit 5α-reductase activity | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20250268972-A1 | 5a-REDUCTASE INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| CN-222677899-U | Calcium folate solvent compounding device | 连云港金康和信药业有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-222677899-U | Calcium folate solvent compounding device | 连云港金康和信药业有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-118742325-A | Methods for preventing or treating diseases or conditions associated with antineoplastic agents | 上海岸阔医药科技有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118715226-A | Compounds and uses thereof | 上海岸阔医药科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-115322966-B | Batch preparation method of calcium folate nanoparticles and method for inducing differentiation of neural stem cells into cholinergic neurons | 山东大学 | 2024-04-16 | — | — | CN | disclosed |
| CN-102958540-A | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations | Bayer Pharma AG | 2013-03-06 | — | — | CN | disclosed |
| US-8017162-B2 | Anti-inflammatory agent | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2011-09-13 | — | — | US | disclosed |
| US-7947662-B2 | Folates, compositions and uses thereof | GNOSIS S.P.A. (IT) | 2011-05-24 | — | — | US | disclosed |
| CN-101970439-A | Folate, composition and use thereof | GNOSIS SPA | 2011-02-09 | — | — | CN | disclosed |
| EP-2245032-A1 | FOLATES, COMPOSITIONS AND USES THEREOF | Gnosis S.p.A. (IT) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009103334-A1 | FOLATES, COMPOSITIONS AND USES THEREOF | GNOSIS S.P.A. (IT) | 2009-08-27 | — | — | WO | disclosed |
| US-20090209543-A1 | FOLATES, COMPOSITIONS AND USES THEREOF | GNOSIS S.P.A. (IT) | 2009-08-20 | — | — | US | disclosed |
| US-20070154575-A1 | Anti-inflammatory agent | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154575-A1 | Anti-inflammatory agent | TNF, IL18, CD14 | KDM4E 2835/4885MEN1 3040/4885ALDH1A1 349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.